| 6.7 |
20.0 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 4.7 |
14.2 |
GO:0043418 |
cysteine biosynthetic process from serine(GO:0006535) homoserine metabolic process(GO:0009092) cysteine biosynthetic process via cystathionine(GO:0019343) transsulfuration(GO:0019346) homocysteine catabolic process(GO:0043418) |
| 4.4 |
17.5 |
GO:0010900 |
regulation of phosphatidylcholine catabolic process(GO:0010899) negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 3.7 |
29.9 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 3.0 |
9.1 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 2.8 |
8.4 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 2.7 |
19.1 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 2.5 |
10.1 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 2.5 |
7.4 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 2.4 |
7.1 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 2.3 |
6.9 |
GO:0046210 |
nitric oxide catabolic process(GO:0046210) |
| 2.0 |
6.1 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 1.8 |
5.4 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 1.8 |
5.4 |
GO:0006273 |
lagging strand elongation(GO:0006273) |
| 1.8 |
7.1 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 1.7 |
3.4 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 1.7 |
8.4 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 1.6 |
4.9 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 1.6 |
6.5 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 1.6 |
9.5 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 1.5 |
1.5 |
GO:0030825 |
positive regulation of cGMP metabolic process(GO:0030825) |
| 1.5 |
4.6 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 1.5 |
13.7 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 1.5 |
22.7 |
GO:0009113 |
purine nucleobase biosynthetic process(GO:0009113) |
| 1.5 |
5.9 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 1.5 |
1.5 |
GO:0034139 |
regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 1.5 |
8.8 |
GO:0060397 |
JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 1.5 |
5.9 |
GO:0048935 |
peripheral nervous system neuron development(GO:0048935) |
| 1.4 |
13.0 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 1.4 |
5.7 |
GO:0014053 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
| 1.4 |
8.5 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 1.4 |
4.2 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 1.4 |
4.2 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 1.4 |
6.9 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 1.4 |
6.8 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 1.4 |
5.4 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 1.3 |
5.4 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 1.3 |
17.4 |
GO:0031498 |
nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
| 1.3 |
4.0 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 1.3 |
3.9 |
GO:0010586 |
miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
| 1.3 |
6.5 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 1.3 |
6.5 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
| 1.3 |
3.9 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 1.3 |
2.6 |
GO:0034723 |
DNA replication-dependent nucleosome organization(GO:0034723) |
| 1.3 |
5.1 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 1.3 |
5.0 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 1.3 |
5.0 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 1.2 |
9.9 |
GO:0033261 |
obsolete regulation of S phase(GO:0033261) |
| 1.2 |
3.6 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 1.2 |
4.8 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 1.2 |
8.4 |
GO:0002478 |
antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
| 1.2 |
5.9 |
GO:0050686 |
negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
| 1.2 |
4.7 |
GO:0060013 |
righting reflex(GO:0060013) |
| 1.2 |
8.2 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
| 1.2 |
9.4 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 1.2 |
7.0 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 1.2 |
8.1 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 1.2 |
3.5 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
| 1.2 |
3.5 |
GO:2000105 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) positive regulation of DNA-dependent DNA replication(GO:2000105) |
| 1.2 |
6.9 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 1.2 |
1.2 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 1.1 |
9.2 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 1.1 |
10.2 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 1.1 |
3.4 |
GO:0046015 |
carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
| 1.1 |
3.4 |
GO:0006188 |
IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
| 1.1 |
2.2 |
GO:1904036 |
negative regulation of epithelial cell apoptotic process(GO:1904036) negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 1.1 |
3.4 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 1.1 |
15.6 |
GO:0006787 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 1.1 |
3.3 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 1.1 |
4.4 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 1.1 |
5.5 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 1.1 |
3.2 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 1.0 |
1.0 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 1.0 |
2.1 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 1.0 |
3.1 |
GO:0031077 |
post-embryonic camera-type eye development(GO:0031077) |
| 1.0 |
6.2 |
GO:0000089 |
mitotic metaphase(GO:0000089) |
| 1.0 |
9.2 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 1.0 |
7.1 |
GO:0071267 |
amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
| 1.0 |
5.0 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 1.0 |
28.8 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 1.0 |
5.0 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.0 |
6.9 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 1.0 |
5.8 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 1.0 |
15.5 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 1.0 |
1.9 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.9 |
4.7 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.9 |
2.8 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.9 |
2.8 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.9 |
2.8 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.9 |
2.8 |
GO:0060318 |
definitive erythrocyte differentiation(GO:0060318) |
| 0.9 |
3.7 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.9 |
3.6 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.9 |
13.5 |
GO:0033151 |
V(D)J recombination(GO:0033151) |
| 0.9 |
7.2 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.9 |
3.6 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.9 |
5.4 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.9 |
0.9 |
GO:0046520 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.9 |
0.9 |
GO:0002367 |
cytokine production involved in immune response(GO:0002367) |
| 0.9 |
6.1 |
GO:1901985 |
positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.9 |
13.9 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.9 |
0.9 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.9 |
6.9 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.9 |
3.5 |
GO:0034442 |
plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.9 |
5.2 |
GO:0006991 |
response to sterol depletion(GO:0006991) |
| 0.9 |
2.6 |
GO:0010041 |
response to iron(III) ion(GO:0010041) positive regulation of histone phosphorylation(GO:0033129) response to DDT(GO:0046680) positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) regulation of chromosome condensation(GO:0060623) cellular response to iron ion(GO:0071281) cellular response to iron(III) ion(GO:0071283) |
| 0.9 |
6.0 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.8 |
5.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.8 |
6.7 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.8 |
4.2 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.8 |
2.5 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.8 |
1.7 |
GO:0098927 |
early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.8 |
4.1 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.8 |
1.6 |
GO:0009221 |
pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
| 0.8 |
2.5 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.8 |
3.3 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.8 |
2.4 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.8 |
3.2 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.8 |
2.4 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.8 |
4.7 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.8 |
2.3 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.8 |
3.1 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.8 |
3.1 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.8 |
2.3 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.8 |
0.8 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.8 |
2.3 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.8 |
1.5 |
GO:0051923 |
protein sulfation(GO:0006477) peptidyl-tyrosine sulfation(GO:0006478) sulfation(GO:0051923) |
| 0.8 |
4.5 |
GO:0043316 |
natural killer cell activation involved in immune response(GO:0002323) cytotoxic T cell degranulation(GO:0043316) natural killer cell degranulation(GO:0043320) |
| 0.8 |
1.5 |
GO:0032898 |
neurotrophin production(GO:0032898) |
| 0.7 |
3.0 |
GO:0051503 |
adenine nucleotide transport(GO:0051503) |
| 0.7 |
3.0 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.7 |
0.7 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
| 0.7 |
13.2 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.7 |
3.6 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.7 |
2.9 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.7 |
2.2 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.7 |
2.9 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.7 |
5.1 |
GO:0031657 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 0.7 |
2.1 |
GO:0005997 |
xylulose metabolic process(GO:0005997) |
| 0.7 |
4.3 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.7 |
6.4 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.7 |
3.5 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) |
| 0.7 |
0.7 |
GO:0043525 |
positive regulation of neuron apoptotic process(GO:0043525) positive regulation of neuron death(GO:1901216) |
| 0.7 |
2.8 |
GO:0001743 |
optic placode formation(GO:0001743) |
| 0.7 |
2.1 |
GO:0000019 |
regulation of mitotic recombination(GO:0000019) |
| 0.7 |
4.8 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.7 |
4.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.7 |
2.1 |
GO:1904742 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.7 |
4.1 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.7 |
8.2 |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.7 |
1.4 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.7 |
3.4 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.7 |
2.0 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.7 |
8.8 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.7 |
2.7 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.7 |
2.0 |
GO:0043247 |
telomere capping(GO:0016233) protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
| 0.7 |
2.0 |
GO:1990170 |
detoxification of cadmium ion(GO:0071585) stress response to cadmium ion(GO:1990170) |
| 0.7 |
6.0 |
GO:1900087 |
traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.7 |
1.3 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.7 |
2.6 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 0.7 |
8.5 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.7 |
2.0 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 0.6 |
3.9 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.6 |
3.2 |
GO:0032329 |
serine transport(GO:0032329) |
| 0.6 |
1.3 |
GO:0016246 |
RNA interference(GO:0016246) |
| 0.6 |
0.6 |
GO:0071504 |
response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 0.6 |
1.9 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.6 |
0.6 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.6 |
2.5 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.6 |
1.9 |
GO:0072136 |
kidney mesenchymal cell proliferation(GO:0072135) metanephric mesenchymal cell proliferation involved in metanephros development(GO:0072136) |
| 0.6 |
1.9 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.6 |
5.7 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.6 |
3.8 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.6 |
2.5 |
GO:0033622 |
integrin activation(GO:0033622) regulation of integrin activation(GO:0033623) positive regulation of integrin activation(GO:0033625) |
| 0.6 |
0.6 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.6 |
2.5 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.6 |
5.0 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.6 |
1.9 |
GO:0071104 |
response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 0.6 |
1.9 |
GO:0034635 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.6 |
0.6 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.6 |
0.6 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.6 |
8.6 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.6 |
1.8 |
GO:0046323 |
glucose import(GO:0046323) |
| 0.6 |
5.5 |
GO:0006546 |
glycine catabolic process(GO:0006546) |
| 0.6 |
0.6 |
GO:0060677 |
ureteric bud elongation(GO:0060677) |
| 0.6 |
13.4 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.6 |
3.0 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.6 |
3.0 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.6 |
1.8 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.6 |
2.4 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.6 |
1.8 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.6 |
1.2 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.6 |
1.8 |
GO:0003289 |
atrial septum development(GO:0003283) septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) atrial septum morphogenesis(GO:0060413) |
| 0.6 |
1.8 |
GO:0000114 |
obsolete regulation of transcription involved in G1 phase of mitotic cell cycle(GO:0000114) |
| 0.6 |
1.2 |
GO:0046174 |
polyol catabolic process(GO:0046174) |
| 0.6 |
5.8 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.6 |
2.3 |
GO:0042816 |
pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
| 0.6 |
2.3 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.6 |
2.3 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.6 |
2.9 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.6 |
15.5 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.6 |
33.8 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.6 |
1.1 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 0.6 |
5.1 |
GO:0009148 |
GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
| 0.6 |
1.7 |
GO:0046368 |
GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) GDP-L-fucose metabolic process(GO:0046368) |
| 0.6 |
0.6 |
GO:0071312 |
cellular response to alkaloid(GO:0071312) |
| 0.6 |
1.1 |
GO:0060487 |
lung epithelium development(GO:0060428) lung epithelial cell differentiation(GO:0060487) |
| 0.6 |
2.2 |
GO:0021759 |
globus pallidus development(GO:0021759) menarche(GO:0042696) |
| 0.6 |
0.6 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.6 |
2.8 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.6 |
2.8 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.6 |
1.7 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.6 |
2.2 |
GO:0033986 |
response to methanol(GO:0033986) response to chromate(GO:0046687) |
| 0.6 |
2.2 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.5 |
4.9 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.5 |
1.1 |
GO:0044340 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.5 |
1.6 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.5 |
1.6 |
GO:0015853 |
adenine transport(GO:0015853) |
| 0.5 |
1.6 |
GO:0019056 |
modulation by virus of host transcription(GO:0019056) regulation of sprouting of injured axon(GO:0048686) positive regulation of sprouting of injured axon(GO:0048687) regulation of axon extension involved in regeneration(GO:0048690) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.5 |
1.6 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.5 |
2.2 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.5 |
1.6 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.5 |
1.6 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.5 |
1.6 |
GO:0009211 |
pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
| 0.5 |
1.6 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.5 |
1.6 |
GO:0021932 |
hindbrain radial glia guided cell migration(GO:0021932) |
| 0.5 |
13.1 |
GO:0017144 |
drug metabolic process(GO:0017144) |
| 0.5 |
3.7 |
GO:0002092 |
positive regulation of receptor internalization(GO:0002092) |
| 0.5 |
3.7 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.5 |
0.5 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.5 |
2.1 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.5 |
5.1 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.5 |
3.6 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.5 |
1.5 |
GO:0021896 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.5 |
2.0 |
GO:0009103 |
lipopolysaccharide biosynthetic process(GO:0009103) |
| 0.5 |
2.0 |
GO:0045299 |
otolith mineralization(GO:0045299) |
| 0.5 |
5.5 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.5 |
2.0 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.5 |
1.5 |
GO:0034626 |
fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.5 |
4.0 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.5 |
1.0 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.5 |
11.4 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.5 |
4.0 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.5 |
0.5 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.5 |
8.4 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.5 |
1.5 |
GO:0071883 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.5 |
2.9 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.5 |
2.9 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.5 |
0.5 |
GO:0042701 |
progesterone secretion(GO:0042701) |
| 0.5 |
3.4 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.5 |
11.6 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.5 |
0.5 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.5 |
4.3 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.5 |
3.9 |
GO:0009304 |
tRNA transcription(GO:0009304) |
| 0.5 |
0.5 |
GO:0048563 |
post-embryonic organ morphogenesis(GO:0048563) |
| 0.5 |
0.5 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.5 |
4.3 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.5 |
2.4 |
GO:0032959 |
inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.5 |
2.4 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.5 |
1.4 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.5 |
1.0 |
GO:0035751 |
lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
| 0.5 |
2.3 |
GO:0003070 |
age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) |
| 0.5 |
1.9 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.5 |
11.2 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.5 |
3.3 |
GO:0042362 |
fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.5 |
1.4 |
GO:0097237 |
cellular response to antibiotic(GO:0071236) cellular response to toxic substance(GO:0097237) |
| 0.5 |
1.9 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.5 |
4.6 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.5 |
3.7 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.5 |
1.8 |
GO:0072207 |
metanephric tubule development(GO:0072170) metanephric epithelium development(GO:0072207) metanephric nephron tubule development(GO:0072234) metanephric nephron epithelium development(GO:0072243) |
| 0.5 |
1.8 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.4 |
1.3 |
GO:0090467 |
L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
| 0.4 |
0.9 |
GO:0010903 |
negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
| 0.4 |
0.9 |
GO:0045667 |
regulation of osteoblast differentiation(GO:0045667) |
| 0.4 |
2.6 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.4 |
3.5 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.4 |
0.4 |
GO:0001508 |
action potential(GO:0001508) |
| 0.4 |
1.3 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.4 |
0.4 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.4 |
0.4 |
GO:0046778 |
modification by virus of host mRNA processing(GO:0046778) |
| 0.4 |
1.7 |
GO:0090003 |
regulation of establishment of protein localization to plasma membrane(GO:0090003) regulation of protein localization to plasma membrane(GO:1903076) regulation of protein localization to cell periphery(GO:1904375) |
| 0.4 |
4.3 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.4 |
3.4 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.4 |
0.9 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.4 |
1.7 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.4 |
1.7 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.4 |
1.3 |
GO:0007090 |
obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
| 0.4 |
8.0 |
GO:0006596 |
polyamine biosynthetic process(GO:0006596) |
| 0.4 |
4.6 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.4 |
1.7 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.4 |
3.4 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.4 |
0.4 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.4 |
3.7 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.4 |
1.2 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.4 |
1.6 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.4 |
1.2 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.4 |
7.0 |
GO:0006386 |
transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
| 0.4 |
3.7 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.4 |
0.4 |
GO:0046668 |
regulation of retinal cell programmed cell death(GO:0046668) |
| 0.4 |
0.8 |
GO:0030952 |
establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.4 |
0.8 |
GO:2000309 |
leukocyte migration involved in inflammatory response(GO:0002523) tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
| 0.4 |
1.6 |
GO:0033160 |
positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.4 |
1.2 |
GO:0007109 |
obsolete cytokinesis, completion of separation(GO:0007109) |
| 0.4 |
1.2 |
GO:0003099 |
positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.4 |
2.0 |
GO:0000080 |
mitotic G1 phase(GO:0000080) |
| 0.4 |
0.4 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.4 |
4.0 |
GO:1902622 |
regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
| 0.4 |
1.6 |
GO:0046831 |
regulation of RNA export from nucleus(GO:0046831) |
| 0.4 |
1.6 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.4 |
1.2 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.4 |
0.8 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.4 |
1.6 |
GO:0033504 |
floor plate development(GO:0033504) |
| 0.4 |
4.7 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.4 |
0.4 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.4 |
0.8 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.4 |
1.6 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.4 |
0.8 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.4 |
1.2 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.4 |
1.2 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.4 |
2.3 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.4 |
19.9 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.4 |
3.5 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.4 |
2.3 |
GO:0060676 |
ureteric bud formation(GO:0060676) mesonephric tubule formation(GO:0072172) |
| 0.4 |
4.2 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.4 |
1.2 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.4 |
1.2 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.4 |
0.4 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.4 |
1.1 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.4 |
3.4 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.4 |
11.5 |
GO:0043487 |
regulation of RNA stability(GO:0043487) |
| 0.4 |
1.9 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.4 |
3.8 |
GO:0045815 |
positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.4 |
0.4 |
GO:0051928 |
positive regulation of calcium ion transport(GO:0051928) |
| 0.4 |
1.9 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.4 |
1.5 |
GO:1901070 |
guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.4 |
2.2 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.4 |
0.7 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.4 |
1.1 |
GO:0021779 |
oligodendrocyte cell fate commitment(GO:0021779) |
| 0.4 |
5.6 |
GO:1903078 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.4 |
3.0 |
GO:0045008 |
depyrimidination(GO:0045008) |
| 0.4 |
1.1 |
GO:0034755 |
iron ion transmembrane transport(GO:0034755) |
| 0.4 |
1.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.4 |
0.7 |
GO:0021675 |
nerve development(GO:0021675) |
| 0.4 |
1.5 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.4 |
0.7 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.4 |
0.7 |
GO:0036260 |
7-methylguanosine mRNA capping(GO:0006370) 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.4 |
8.4 |
GO:0046834 |
lipid phosphorylation(GO:0046834) |
| 0.4 |
2.6 |
GO:0070189 |
kynurenine metabolic process(GO:0070189) |
| 0.4 |
2.6 |
GO:0008334 |
histone mRNA metabolic process(GO:0008334) |
| 0.4 |
1.8 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.4 |
1.8 |
GO:0032099 |
negative regulation of appetite(GO:0032099) |
| 0.4 |
3.3 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.4 |
4.4 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.4 |
10.5 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.4 |
2.5 |
GO:0046653 |
tetrahydrofolate metabolic process(GO:0046653) |
| 0.4 |
6.9 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.4 |
1.1 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.4 |
1.1 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.4 |
1.1 |
GO:1901142 |
insulin processing(GO:0030070) insulin metabolic process(GO:1901142) |
| 0.4 |
4.3 |
GO:0014037 |
Schwann cell differentiation(GO:0014037) |
| 0.4 |
1.4 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.4 |
0.7 |
GO:0090267 |
positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.4 |
7.4 |
GO:0001662 |
behavioral fear response(GO:0001662) |
| 0.4 |
2.1 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.4 |
11.3 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.4 |
2.8 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.3 |
7.3 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) |
| 0.3 |
1.7 |
GO:0045010 |
actin nucleation(GO:0045010) |
| 0.3 |
0.3 |
GO:0001807 |
type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
| 0.3 |
5.2 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.3 |
1.4 |
GO:0032354 |
response to follicle-stimulating hormone(GO:0032354) |
| 0.3 |
3.4 |
GO:0009713 |
catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
| 0.3 |
0.3 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.3 |
9.9 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.3 |
1.4 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.3 |
0.3 |
GO:0045077 |
negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
| 0.3 |
0.7 |
GO:0015865 |
purine nucleotide transport(GO:0015865) |
| 0.3 |
1.0 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.3 |
6.1 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.3 |
2.7 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.3 |
6.7 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
| 0.3 |
0.7 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.3 |
1.3 |
GO:0032495 |
response to muramyl dipeptide(GO:0032495) |
| 0.3 |
0.3 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.3 |
1.7 |
GO:0032674 |
interleukin-5 production(GO:0032634) regulation of interleukin-5 production(GO:0032674) |
| 0.3 |
1.3 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
| 0.3 |
1.3 |
GO:0042098 |
T cell proliferation(GO:0042098) |
| 0.3 |
8.6 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.3 |
1.0 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.3 |
0.3 |
GO:0045350 |
interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.3 |
1.6 |
GO:0006783 |
heme biosynthetic process(GO:0006783) heme metabolic process(GO:0042168) |
| 0.3 |
2.3 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.3 |
0.3 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.3 |
1.3 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.3 |
1.0 |
GO:0033146 |
regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
| 0.3 |
0.6 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.3 |
1.6 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.3 |
1.3 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.3 |
1.0 |
GO:0040001 |
establishment of mitotic spindle localization(GO:0040001) |
| 0.3 |
1.0 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.3 |
1.3 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.3 |
1.3 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.3 |
4.5 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.3 |
1.9 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.3 |
8.6 |
GO:0000288 |
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
| 0.3 |
4.4 |
GO:0006978 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
| 0.3 |
1.9 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.3 |
0.9 |
GO:0007584 |
response to nutrient(GO:0007584) |
| 0.3 |
6.3 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.3 |
0.9 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.3 |
1.2 |
GO:0018216 |
peptidyl-arginine methylation(GO:0018216) |
| 0.3 |
0.9 |
GO:0032770 |
positive regulation of monooxygenase activity(GO:0032770) |
| 0.3 |
0.6 |
GO:0060633 |
negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.3 |
0.9 |
GO:0009309 |
amine biosynthetic process(GO:0009309) |
| 0.3 |
0.3 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.3 |
3.7 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.3 |
7.0 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.3 |
11.9 |
GO:0030218 |
erythrocyte differentiation(GO:0030218) |
| 0.3 |
0.3 |
GO:0051446 |
positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
| 0.3 |
0.9 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.3 |
1.2 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.3 |
0.6 |
GO:0007140 |
male meiosis(GO:0007140) |
| 0.3 |
3.6 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.3 |
0.9 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.3 |
3.0 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.3 |
1.5 |
GO:0045953 |
negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.3 |
3.3 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.3 |
3.9 |
GO:0032232 |
negative regulation of actin filament bundle assembly(GO:0032232) |
| 0.3 |
0.3 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.3 |
0.6 |
GO:0060285 |
cilium movement(GO:0003341) cilium-dependent cell motility(GO:0060285) |
| 0.3 |
1.2 |
GO:0042100 |
B cell proliferation(GO:0042100) |
| 0.3 |
10.3 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.3 |
1.5 |
GO:0007215 |
glutamate receptor signaling pathway(GO:0007215) |
| 0.3 |
5.3 |
GO:0046676 |
negative regulation of insulin secretion(GO:0046676) |
| 0.3 |
6.2 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.3 |
12.0 |
GO:0060041 |
retina development in camera-type eye(GO:0060041) |
| 0.3 |
1.2 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.3 |
0.3 |
GO:0043604 |
amide biosynthetic process(GO:0043604) |
| 0.3 |
0.9 |
GO:0016458 |
gene silencing(GO:0016458) |
| 0.3 |
1.2 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
| 0.3 |
1.2 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.3 |
0.3 |
GO:0072202 |
cell differentiation involved in metanephros development(GO:0072202) |
| 0.3 |
4.0 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.3 |
0.9 |
GO:0052257 |
pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) |
| 0.3 |
2.6 |
GO:0046902 |
regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
| 0.3 |
3.4 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.3 |
0.6 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.3 |
0.8 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.3 |
1.1 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.3 |
5.1 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.3 |
3.1 |
GO:0009086 |
methionine biosynthetic process(GO:0009086) |
| 0.3 |
1.4 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.3 |
2.2 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.3 |
0.3 |
GO:0043647 |
inositol phosphate metabolic process(GO:0043647) |
| 0.3 |
4.1 |
GO:0019400 |
glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
| 0.3 |
0.3 |
GO:0043628 |
ncRNA 3'-end processing(GO:0043628) |
| 0.3 |
0.8 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.3 |
1.1 |
GO:0015012 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.3 |
0.8 |
GO:0021937 |
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.3 |
0.3 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.3 |
0.3 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.3 |
1.4 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 |
0.5 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.3 |
12.1 |
GO:0009791 |
post-embryonic development(GO:0009791) |
| 0.3 |
1.1 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.3 |
0.8 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.3 |
2.1 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
| 0.3 |
1.3 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.3 |
4.0 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
| 0.3 |
4.3 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.3 |
0.8 |
GO:0071848 |
regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) TNFSF11-mediated signaling pathway(GO:0071847) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.3 |
1.3 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.3 |
47.7 |
GO:0000375 |
RNA splicing, via transesterification reactions(GO:0000375) |
| 0.3 |
0.5 |
GO:0034392 |
negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.3 |
0.8 |
GO:0006325 |
chromatin organization(GO:0006325) |
| 0.3 |
1.8 |
GO:0006310 |
DNA recombination(GO:0006310) |
| 0.3 |
2.6 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.3 |
0.8 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.3 |
0.8 |
GO:0003077 |
obsolete negative regulation of diuresis(GO:0003077) |
| 0.3 |
0.8 |
GO:0098727 |
maintenance of cell number(GO:0098727) |
| 0.3 |
0.3 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.3 |
2.3 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.3 |
25.4 |
GO:0006333 |
chromatin assembly or disassembly(GO:0006333) |
| 0.3 |
1.5 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.3 |
2.5 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.3 |
0.5 |
GO:0031558 |
obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
| 0.2 |
1.0 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.2 |
0.2 |
GO:0042339 |
keratan sulfate metabolic process(GO:0042339) |
| 0.2 |
0.5 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.2 |
0.5 |
GO:0002883 |
hypersensitivity(GO:0002524) regulation of hypersensitivity(GO:0002883) positive regulation of hypersensitivity(GO:0002885) |
| 0.2 |
1.7 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.2 |
0.7 |
GO:0051712 |
positive regulation of killing of cells of other organism(GO:0051712) |
| 0.2 |
1.2 |
GO:0048550 |
negative regulation of pinocytosis(GO:0048550) |
| 0.2 |
0.2 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.2 |
0.7 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.2 |
1.0 |
GO:0036336 |
dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
| 0.2 |
1.9 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.2 |
0.5 |
GO:0034101 |
erythrocyte homeostasis(GO:0034101) |
| 0.2 |
1.4 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.2 |
4.6 |
GO:0045987 |
positive regulation of smooth muscle contraction(GO:0045987) |
| 0.2 |
0.2 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.2 |
1.0 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.2 |
6.5 |
GO:0060334 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 |
0.5 |
GO:0060748 |
tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.2 |
0.5 |
GO:0003176 |
aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) notochord formation(GO:0014028) notochord morphogenesis(GO:0048570) |
| 0.2 |
8.4 |
GO:0008630 |
intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.2 |
4.6 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.2 |
16.4 |
GO:0006094 |
gluconeogenesis(GO:0006094) |
| 0.2 |
0.5 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 |
1.7 |
GO:0031124 |
mRNA 3'-end processing(GO:0031124) |
| 0.2 |
0.7 |
GO:0052803 |
imidazole-containing compound metabolic process(GO:0052803) |
| 0.2 |
0.7 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) |
| 0.2 |
0.9 |
GO:0045768 |
obsolete positive regulation of anti-apoptosis(GO:0045768) |
| 0.2 |
0.2 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.2 |
3.3 |
GO:0019221 |
cytokine-mediated signaling pathway(GO:0019221) |
| 0.2 |
0.9 |
GO:0031622 |
regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
| 0.2 |
1.2 |
GO:0070293 |
renal absorption(GO:0070293) |
| 0.2 |
1.2 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.2 |
1.2 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.2 |
0.2 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) |
| 0.2 |
15.3 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.2 |
0.5 |
GO:0043631 |
RNA polyadenylation(GO:0043631) |
| 0.2 |
0.5 |
GO:0043368 |
positive T cell selection(GO:0043368) |
| 0.2 |
11.2 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.2 |
12.1 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.2 |
2.3 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.2 |
0.2 |
GO:0051531 |
NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.2 |
0.2 |
GO:1902745 |
positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
| 0.2 |
5.6 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.2 |
0.9 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.2 |
0.9 |
GO:0021915 |
neural tube development(GO:0021915) |
| 0.2 |
0.9 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.2 |
0.7 |
GO:0070253 |
somatostatin secretion(GO:0070253) |
| 0.2 |
0.9 |
GO:0033522 |
histone H2A ubiquitination(GO:0033522) |
| 0.2 |
0.4 |
GO:0007518 |
myoblast fate determination(GO:0007518) |
| 0.2 |
2.0 |
GO:0000090 |
mitotic anaphase(GO:0000090) |
| 0.2 |
1.5 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.2 |
18.0 |
GO:0000216 |
obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
| 0.2 |
2.0 |
GO:0032613 |
interleukin-10 production(GO:0032613) |
| 0.2 |
1.3 |
GO:0048302 |
isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
| 0.2 |
0.4 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.2 |
2.0 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.2 |
1.8 |
GO:0015992 |
proton transport(GO:0015992) |
| 0.2 |
1.1 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.2 |
1.3 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.2 |
0.6 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 |
0.2 |
GO:0002514 |
B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
| 0.2 |
0.6 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.2 |
0.9 |
GO:0034204 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.2 |
1.1 |
GO:0008089 |
anterograde axonal transport(GO:0008089) axonal transport(GO:0098930) |
| 0.2 |
0.4 |
GO:0042640 |
anagen(GO:0042640) |
| 0.2 |
1.5 |
GO:0021903 |
rostrocaudal neural tube patterning(GO:0021903) |
| 0.2 |
1.5 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.2 |
0.8 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.2 |
1.3 |
GO:0032868 |
response to insulin(GO:0032868) |
| 0.2 |
0.6 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.2 |
6.5 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.2 |
0.2 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.2 |
0.6 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.2 |
1.0 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.2 |
0.4 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.2 |
0.2 |
GO:0001895 |
retina homeostasis(GO:0001895) photoreceptor cell maintenance(GO:0045494) |
| 0.2 |
0.4 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.2 |
7.4 |
GO:0046777 |
protein autophosphorylation(GO:0046777) |
| 0.2 |
1.2 |
GO:0015801 |
aromatic amino acid transport(GO:0015801) |
| 0.2 |
1.0 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.2 |
1.0 |
GO:0031623 |
receptor internalization(GO:0031623) |
| 0.2 |
8.0 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.2 |
0.2 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.2 |
0.6 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.2 |
1.6 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.2 |
0.2 |
GO:0003056 |
regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.2 |
2.6 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.2 |
4.6 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.2 |
0.8 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.2 |
2.2 |
GO:0042743 |
hydrogen peroxide metabolic process(GO:0042743) |
| 0.2 |
1.4 |
GO:0030217 |
T cell differentiation(GO:0030217) |
| 0.2 |
0.6 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.2 |
0.6 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.2 |
1.0 |
GO:0051917 |
regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
| 0.2 |
1.6 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.2 |
0.4 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.2 |
0.2 |
GO:0003097 |
renal water transport(GO:0003097) |
| 0.2 |
1.6 |
GO:0051319 |
mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
| 0.2 |
1.8 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 |
0.2 |
GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
| 0.2 |
0.6 |
GO:0006530 |
asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
| 0.2 |
0.2 |
GO:0051591 |
response to cAMP(GO:0051591) |
| 0.2 |
0.8 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.2 |
4.1 |
GO:0018022 |
peptidyl-lysine methylation(GO:0018022) |
| 0.2 |
0.6 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.2 |
2.1 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.2 |
0.4 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.2 |
1.0 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.2 |
0.6 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.2 |
2.5 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.2 |
0.2 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.2 |
1.9 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.2 |
1.1 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.2 |
0.4 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.2 |
11.1 |
GO:0034339 |
obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
| 0.2 |
1.1 |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.2 |
0.7 |
GO:0051299 |
centrosome separation(GO:0051299) |
| 0.2 |
0.2 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 |
0.7 |
GO:0001825 |
blastocyst formation(GO:0001825) |
| 0.2 |
0.7 |
GO:0042262 |
DNA protection(GO:0042262) |
| 0.2 |
1.1 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 |
0.4 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.2 |
3.9 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.2 |
3.1 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
| 0.2 |
1.1 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.2 |
1.5 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.2 |
1.6 |
GO:0032651 |
regulation of interleukin-1 beta production(GO:0032651) |
| 0.2 |
1.8 |
GO:0071593 |
T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
| 0.2 |
1.3 |
GO:0009948 |
anterior/posterior axis specification(GO:0009948) |
| 0.2 |
1.6 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.2 |
0.9 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.2 |
0.5 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.2 |
1.4 |
GO:0006448 |
regulation of translational elongation(GO:0006448) |
| 0.2 |
0.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.2 |
4.3 |
GO:1903902 |
positive regulation of viral process(GO:0048524) positive regulation of viral life cycle(GO:1903902) |
| 0.2 |
0.4 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) cleavage involved in rRNA processing(GO:0000469) endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) maturation of SSU-rRNA(GO:0030490) RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.2 |
1.9 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.2 |
0.4 |
GO:0001964 |
startle response(GO:0001964) |
| 0.2 |
2.1 |
GO:0006349 |
regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.2 |
1.4 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.2 |
3.8 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.2 |
1.0 |
GO:0032916 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.2 |
0.7 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.2 |
1.4 |
GO:0009744 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.2 |
0.5 |
GO:0002684 |
positive regulation of immune system process(GO:0002684) |
| 0.2 |
0.5 |
GO:0050710 |
negative regulation of cytokine secretion(GO:0050710) |
| 0.2 |
1.0 |
GO:0045072 |
regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 |
0.7 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
0.5 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.2 |
0.3 |
GO:0015851 |
nucleobase transport(GO:0015851) |
| 0.2 |
0.8 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.2 |
8.4 |
GO:0010827 |
regulation of glucose transport(GO:0010827) |
| 0.2 |
0.7 |
GO:2001259 |
positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
| 0.2 |
0.2 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.2 |
2.5 |
GO:0007094 |
mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
| 0.2 |
0.7 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
1.6 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.2 |
1.3 |
GO:0006303 |
double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.2 |
0.8 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.2 |
0.2 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.2 |
1.8 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.2 |
0.2 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.2 |
2.2 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) |
| 0.2 |
0.2 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.2 |
1.8 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.2 |
0.6 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.2 |
0.8 |
GO:1902583 |
multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
| 0.2 |
1.9 |
GO:0042354 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.2 |
1.1 |
GO:0075713 |
establishment of viral latency(GO:0019043) establishment of integrated proviral latency(GO:0075713) |
| 0.2 |
0.2 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.2 |
0.3 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.2 |
0.5 |
GO:0046886 |
positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.2 |
0.8 |
GO:0050709 |
negative regulation of protein secretion(GO:0050709) |
| 0.2 |
0.9 |
GO:0051149 |
positive regulation of muscle cell differentiation(GO:0051149) |
| 0.2 |
0.5 |
GO:0051597 |
response to methylmercury(GO:0051597) |
| 0.2 |
2.3 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.2 |
0.5 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.2 |
0.6 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.2 |
0.3 |
GO:0051438 |
regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.2 |
0.3 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 |
0.4 |
GO:0045885 |
obsolete positive regulation of survival gene product expression(GO:0045885) |
| 0.1 |
1.2 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 |
0.3 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.1 |
2.2 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.1 |
1.0 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
| 0.1 |
0.3 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.1 |
1.9 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
0.1 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.1 |
1.2 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.1 |
0.1 |
GO:0060872 |
semicircular canal development(GO:0060872) |
| 0.1 |
1.7 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 |
0.4 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.1 |
5.1 |
GO:0006399 |
tRNA metabolic process(GO:0006399) |
| 0.1 |
0.6 |
GO:0043406 |
positive regulation of MAP kinase activity(GO:0043406) |
| 0.1 |
2.9 |
GO:0036503 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
| 0.1 |
2.4 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 |
0.7 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.3 |
GO:0000726 |
non-recombinational repair(GO:0000726) |
| 0.1 |
0.8 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
| 0.1 |
20.9 |
GO:0016568 |
chromatin modification(GO:0016568) |
| 0.1 |
0.3 |
GO:0060795 |
cell fate commitment involved in formation of primary germ layer(GO:0060795) |
| 0.1 |
0.4 |
GO:0030099 |
myeloid cell differentiation(GO:0030099) |
| 0.1 |
2.6 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.1 |
0.4 |
GO:0021615 |
glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.1 |
0.3 |
GO:0033002 |
muscle cell proliferation(GO:0033002) |
| 0.1 |
0.3 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.1 |
1.6 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 |
0.3 |
GO:0042727 |
flavin-containing compound metabolic process(GO:0042726) flavin-containing compound biosynthetic process(GO:0042727) |
| 0.1 |
0.1 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.3 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.1 |
0.4 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.1 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
0.1 |
GO:0000305 |
response to oxygen radical(GO:0000305) |
| 0.1 |
1.0 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 |
1.0 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.1 |
1.1 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.1 |
5.8 |
GO:0008643 |
carbohydrate transport(GO:0008643) |
| 0.1 |
1.0 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
2.5 |
GO:0006885 |
regulation of pH(GO:0006885) |
| 0.1 |
2.4 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.1 |
0.9 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.1 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.4 |
GO:0006839 |
mitochondrial transport(GO:0006839) |
| 0.1 |
1.1 |
GO:0045076 |
regulation of interleukin-2 biosynthetic process(GO:0045076) |
| 0.1 |
0.2 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.1 |
0.7 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.1 |
0.5 |
GO:0097061 |
dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
| 0.1 |
12.4 |
GO:0007254 |
JNK cascade(GO:0007254) |
| 0.1 |
0.4 |
GO:0009067 |
aspartate family amino acid biosynthetic process(GO:0009067) |
| 0.1 |
0.6 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.1 |
0.7 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.1 |
0.4 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.1 |
0.6 |
GO:0060444 |
branching involved in mammary gland duct morphogenesis(GO:0060444) |
| 0.1 |
1.1 |
GO:0051324 |
prophase(GO:0051324) |
| 0.1 |
0.9 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.1 |
13.8 |
GO:0022904 |
respiratory electron transport chain(GO:0022904) |
| 0.1 |
0.2 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.1 |
2.6 |
GO:0031647 |
regulation of protein stability(GO:0031647) |
| 0.1 |
0.5 |
GO:0042637 |
catagen(GO:0042637) hair cycle phase(GO:0044851) hair follicle maturation(GO:0048820) |
| 0.1 |
2.8 |
GO:0016079 |
synaptic vesicle exocytosis(GO:0016079) |
| 0.1 |
0.3 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 0.1 |
0.2 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 |
0.5 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.1 |
0.2 |
GO:0051972 |
regulation of telomerase activity(GO:0051972) |
| 0.1 |
0.2 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.1 |
0.5 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.1 |
0.1 |
GO:0030278 |
regulation of ossification(GO:0030278) |
| 0.1 |
0.4 |
GO:0001570 |
vasculogenesis(GO:0001570) |
| 0.1 |
2.5 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.1 |
0.8 |
GO:0035303 |
regulation of dephosphorylation(GO:0035303) |
| 0.1 |
2.6 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.1 |
0.6 |
GO:0001880 |
Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
| 0.1 |
0.2 |
GO:0031018 |
endocrine pancreas development(GO:0031018) |
| 0.1 |
2.3 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 |
0.3 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.1 |
0.4 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.1 |
0.5 |
GO:0060603 |
mammary gland duct morphogenesis(GO:0060603) |
| 0.1 |
1.5 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
| 0.1 |
1.6 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 |
1.2 |
GO:0002026 |
regulation of the force of heart contraction(GO:0002026) |
| 0.1 |
0.1 |
GO:0032096 |
negative regulation of response to food(GO:0032096) |
| 0.1 |
0.2 |
GO:0051445 |
regulation of meiotic nuclear division(GO:0040020) regulation of meiotic cell cycle(GO:0051445) |
| 0.1 |
1.2 |
GO:0051099 |
positive regulation of binding(GO:0051099) |
| 0.1 |
0.4 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.1 |
1.0 |
GO:0030073 |
insulin secretion(GO:0030073) |
| 0.1 |
0.2 |
GO:0034440 |
fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
| 0.1 |
0.4 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
2.4 |
GO:0051781 |
positive regulation of cell division(GO:0051781) |
| 0.1 |
0.4 |
GO:0043650 |
dicarboxylic acid biosynthetic process(GO:0043650) |
| 0.1 |
16.5 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 0.1 |
0.1 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.1 |
11.5 |
GO:0006112 |
energy reserve metabolic process(GO:0006112) |
| 0.1 |
0.5 |
GO:0031663 |
lipopolysaccharide-mediated signaling pathway(GO:0031663) |
| 0.1 |
0.2 |
GO:0014741 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
| 0.1 |
0.5 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
| 0.1 |
0.1 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.1 |
0.3 |
GO:0002377 |
immunoglobulin production(GO:0002377) |
| 0.1 |
1.2 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
5.9 |
GO:0043161 |
proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
| 0.1 |
0.9 |
GO:2000104 |
regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) negative regulation of DNA-dependent DNA replication(GO:2000104) |
| 0.1 |
0.5 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.1 |
0.4 |
GO:0035264 |
multicellular organism growth(GO:0035264) |
| 0.1 |
0.3 |
GO:0097696 |
JAK-STAT cascade(GO:0007259) STAT cascade(GO:0097696) |
| 0.1 |
0.2 |
GO:0010458 |
exit from mitosis(GO:0010458) |
| 0.1 |
0.3 |
GO:0046320 |
regulation of fatty acid oxidation(GO:0046320) |
| 0.1 |
0.3 |
GO:0008637 |
apoptotic mitochondrial changes(GO:0008637) |
| 0.1 |
0.7 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.1 |
11.5 |
GO:0006397 |
mRNA processing(GO:0006397) |
| 0.1 |
0.3 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.1 |
0.4 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.1 |
0.1 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) regulation of resting membrane potential(GO:0060075) |
| 0.1 |
0.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
22.4 |
GO:0007283 |
spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
| 0.1 |
0.3 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.1 |
2.4 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
| 0.1 |
0.4 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 0.1 |
0.5 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
1.9 |
GO:0002504 |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.1 |
0.3 |
GO:0071156 |
regulation of cell cycle arrest(GO:0071156) |
| 0.1 |
0.3 |
GO:0034126 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) positive regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034126) |
| 0.1 |
1.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
1.0 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.3 |
GO:0050999 |
regulation of monooxygenase activity(GO:0032768) regulation of nitric-oxide synthase activity(GO:0050999) |
| 0.1 |
0.2 |
GO:0030147 |
obsolete natriuresis(GO:0030147) |
| 0.1 |
0.1 |
GO:0032196 |
transposition, DNA-mediated(GO:0006313) transposition(GO:0032196) |
| 0.1 |
0.9 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.1 |
0.3 |
GO:0030219 |
megakaryocyte differentiation(GO:0030219) |
| 0.1 |
1.0 |
GO:0042438 |
melanin biosynthetic process(GO:0042438) |
| 0.1 |
0.9 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.1 |
0.4 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
| 0.1 |
0.2 |
GO:1904396 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) regulation of neuromuscular junction development(GO:1904396) |
| 0.1 |
0.2 |
GO:0048075 |
regulation of eye pigmentation(GO:0048073) positive regulation of eye pigmentation(GO:0048075) |
| 0.1 |
1.6 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.4 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.1 |
0.2 |
GO:0070942 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) |
| 0.1 |
0.3 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.1 |
0.2 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.1 |
0.2 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 0.1 |
0.5 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 |
0.5 |
GO:0010766 |
negative regulation of sodium ion transport(GO:0010766) |
| 0.1 |
0.5 |
GO:0033157 |
regulation of intracellular protein transport(GO:0033157) |
| 0.1 |
0.3 |
GO:0009082 |
branched-chain amino acid biosynthetic process(GO:0009082) |
| 0.1 |
0.5 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) sensory perception of bitter taste(GO:0050913) |
| 0.1 |
0.2 |
GO:0060828 |
regulation of canonical Wnt signaling pathway(GO:0060828) |
| 0.1 |
0.2 |
GO:0007051 |
spindle organization(GO:0007051) |
| 0.1 |
0.1 |
GO:0051932 |
regulation of synaptic transmission, GABAergic(GO:0032228) synaptic transmission, GABAergic(GO:0051932) |
| 0.1 |
0.3 |
GO:0007635 |
chemosensory behavior(GO:0007635) |
| 0.1 |
0.8 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.1 |
0.2 |
GO:0042542 |
response to hydrogen peroxide(GO:0042542) |
| 0.1 |
0.5 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
1.1 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.1 |
0.2 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.1 |
0.3 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.1 |
1.3 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
6.1 |
GO:0006959 |
humoral immune response(GO:0006959) |
| 0.1 |
0.4 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.1 |
0.1 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 |
1.0 |
GO:0006490 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
0.2 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.1 |
0.1 |
GO:0051168 |
nuclear export(GO:0051168) |
| 0.1 |
0.3 |
GO:0007422 |
peripheral nervous system development(GO:0007422) |
| 0.1 |
0.8 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.1 |
0.1 |
GO:0060457 |
negative regulation of digestive system process(GO:0060457) |
| 0.1 |
1.6 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.1 |
5.7 |
GO:0008286 |
insulin receptor signaling pathway(GO:0008286) |
| 0.1 |
0.3 |
GO:1990542 |
mitochondrial transmembrane transport(GO:1990542) |
| 0.1 |
0.1 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.1 |
1.0 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
0.2 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 |
0.4 |
GO:0051353 |
positive regulation of oxidoreductase activity(GO:0051353) |
| 0.1 |
0.1 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.1 |
0.2 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.1 |
0.1 |
GO:0043536 |
positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.1 |
0.3 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.1 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.1 |
0.1 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.1 |
0.4 |
GO:0030183 |
B cell differentiation(GO:0030183) |
| 0.1 |
0.7 |
GO:0050663 |
cytokine secretion(GO:0050663) |
| 0.1 |
2.0 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.1 |
0.2 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
0.6 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
0.1 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.1 |
0.1 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.1 |
0.5 |
GO:0045123 |
cellular extravasation(GO:0045123) |
| 0.1 |
0.2 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.1 |
1.2 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.1 |
0.4 |
GO:0048296 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.1 |
0.2 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
0.2 |
GO:0006922 |
obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
| 0.1 |
0.3 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.1 |
0.2 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.1 |
0.1 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.1 |
0.3 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.1 |
0.7 |
GO:0045333 |
cellular respiration(GO:0045333) |
| 0.1 |
0.2 |
GO:0019059 |
obsolete initiation of viral infection(GO:0019059) |
| 0.1 |
0.3 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.1 |
0.1 |
GO:0001822 |
kidney development(GO:0001822) |
| 0.1 |
0.4 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.7 |
GO:0007224 |
smoothened signaling pathway(GO:0007224) |
| 0.1 |
0.5 |
GO:0006812 |
cation transport(GO:0006812) |
| 0.1 |
0.3 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 0.1 |
0.1 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.1 |
0.3 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 |
0.1 |
GO:0042455 |
ribonucleoside biosynthetic process(GO:0042455) |
| 0.1 |
0.1 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.1 |
0.1 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.1 |
0.3 |
GO:0032769 |
negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.0 |
3.4 |
GO:0008203 |
cholesterol metabolic process(GO:0008203) |
| 0.0 |
0.1 |
GO:0048865 |
stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
| 0.0 |
0.4 |
GO:0030010 |
establishment of cell polarity(GO:0030010) |
| 0.0 |
15.7 |
GO:0006412 |
translation(GO:0006412) |
| 0.0 |
0.6 |
GO:0042994 |
cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.0 |
0.3 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.1 |
GO:0001935 |
endothelial cell proliferation(GO:0001935) regulation of endothelial cell proliferation(GO:0001936) |
| 0.0 |
0.0 |
GO:0010891 |
regulation of sequestering of triglyceride(GO:0010889) negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.0 |
0.1 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.0 |
0.1 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.0 |
1.3 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.0 |
4.5 |
GO:0006644 |
phospholipid metabolic process(GO:0006644) |
| 0.0 |
0.1 |
GO:0015802 |
basic amino acid transport(GO:0015802) |
| 0.0 |
0.1 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.1 |
GO:0051784 |
negative regulation of mitotic nuclear division(GO:0045839) negative regulation of nuclear division(GO:0051784) |
| 0.0 |
0.0 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
0.1 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.0 |
1.6 |
GO:0000279 |
M phase(GO:0000279) |
| 0.0 |
0.2 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.0 |
0.1 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.0 |
0.1 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.0 |
0.0 |
GO:0072523 |
purine-containing compound catabolic process(GO:0072523) |
| 0.0 |
0.2 |
GO:0003416 |
endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) bone growth(GO:0098868) |
| 0.0 |
0.3 |
GO:0010506 |
regulation of autophagy(GO:0010506) |
| 0.0 |
0.0 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.0 |
0.1 |
GO:0043030 |
regulation of macrophage activation(GO:0043030) |
| 0.0 |
0.2 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) |
| 0.0 |
0.1 |
GO:0010629 |
negative regulation of gene expression(GO:0010629) |
| 0.0 |
0.5 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.0 |
0.0 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
| 0.0 |
0.3 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
1.7 |
GO:0006909 |
phagocytosis(GO:0006909) |
| 0.0 |
0.4 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.1 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.0 |
0.1 |
GO:0010759 |
regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.0 |
0.3 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
| 0.0 |
0.3 |
GO:0006006 |
glucose metabolic process(GO:0006006) |
| 0.0 |
0.1 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.0 |
0.0 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.0 |
0.1 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.0 |
0.2 |
GO:0034644 |
cellular response to UV(GO:0034644) |
| 0.0 |
0.2 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.0 |
0.2 |
GO:0072073 |
kidney epithelium development(GO:0072073) |
| 0.0 |
0.2 |
GO:0001942 |
hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) molting cycle(GO:0042303) hair cycle(GO:0042633) skin epidermis development(GO:0098773) |
| 0.0 |
0.2 |
GO:0035094 |
response to nicotine(GO:0035094) |
| 0.0 |
0.1 |
GO:0048002 |
antigen processing and presentation of peptide antigen(GO:0048002) |
| 0.0 |
0.3 |
GO:0006302 |
double-strand break repair(GO:0006302) |
| 0.0 |
0.2 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.0 |
0.1 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.0 |
0.5 |
GO:1903037 |
regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
| 0.0 |
0.5 |
GO:0042472 |
inner ear morphogenesis(GO:0042472) |
| 0.0 |
0.0 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.0 |
6.1 |
GO:0051056 |
regulation of small GTPase mediated signal transduction(GO:0051056) |
| 0.0 |
0.0 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.0 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.0 |
0.1 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.0 |
0.3 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
0.2 |
GO:0070664 |
negative regulation of leukocyte proliferation(GO:0070664) |
| 0.0 |
1.0 |
GO:0006898 |
receptor-mediated endocytosis(GO:0006898) |
| 0.0 |
30.0 |
GO:0006351 |
transcription, DNA-templated(GO:0006351) nucleic acid-templated transcription(GO:0097659) |
| 0.0 |
0.1 |
GO:0010595 |
positive regulation of endothelial cell migration(GO:0010595) |
| 0.0 |
0.1 |
GO:0006541 |
glutamine metabolic process(GO:0006541) |
| 0.0 |
0.2 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.0 |
1.1 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.0 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.0 |
0.1 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 |
0.0 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 |
0.0 |
GO:0070120 |
ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.0 |
0.0 |
GO:0044241 |
lipid digestion(GO:0044241) |
| 0.0 |
0.4 |
GO:0046031 |
glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) purine nucleoside diphosphate metabolic process(GO:0009135) purine ribonucleoside diphosphate metabolic process(GO:0009179) ADP metabolic process(GO:0046031) |
| 0.0 |
0.0 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.0 |
0.2 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.1 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.0 |
0.1 |
GO:0019674 |
NAD metabolic process(GO:0019674) |
| 0.0 |
0.1 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.0 |
0.0 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.0 |
0.8 |
GO:0006836 |
neurotransmitter transport(GO:0006836) |
| 0.0 |
0.0 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.0 |
0.1 |
GO:0048015 |
phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
| 0.0 |
0.0 |
GO:0051956 |
negative regulation of amino acid transport(GO:0051956) |
| 0.0 |
0.6 |
GO:0007018 |
microtubule-based movement(GO:0007018) |
| 0.0 |
0.7 |
GO:0006511 |
ubiquitin-dependent protein catabolic process(GO:0006511) |
